Login / Signup
Pyoderma gangrenosum triggered by switching from adalimumab to secukinumab.
Kayo Jin
Yasushi Matsuzaki
Eijiro Akasaka
Hajime Nakano
Daisuke Sawamura
Published in:
The Journal of dermatology (2018)
Keyphrases
</>
ankylosing spondylitis
rheumatoid arthritis
juvenile idiopathic arthritis
disease activity
hidradenitis suppurativa
ulcerative colitis
systemic lupus erythematosus